Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
What
clinical
2
×
medical
presented
2
×
press
release
study
adverse
amaranth
announces
aptitude
bioresorbable
cardiac
cardiology
clinically
commercial
company
company's
developing
device
direct
driven
eluting
europcr
events
failure
final
follow
generation
ii
interventional
lesion
mace
major
market
micron
month
outcomes
outstanding
provides
renascent
Language
Current search:
presented
×
clinical
×
@venturebeat.com
6 years ago
Amaranth Medical Provides Clinical and Commercial Update on 115-micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
@venturebeat.com
6 years ago
Svelte Medical Systems Announces Sustained Outstanding Outcomes in Clinical Studies
